Organic electroluminescent materials and devices

US12250875B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12250875-B2
Application numberUS-202318504375-A
CountryUS
Kind codeB2
Filing dateNov 8, 2023
Priority dateAug 15, 2019
Publication dateMar 11, 2025
Grant dateMar 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are compounds comprising a ligand L A of Formula I where the ligand L A is coordinated to Ir.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound comprising a ligand L A of Formula I wherein: A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 3 and Z 2 are each independently C or N; K 3 and Ware each independently a direct bond, O, or S; X 1 , X 2 , and X 3 are each independently C or N, at least one of X′, X 2 , and X 3 is C; X is O or NR′; R A and R B each represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; each of R, R′, R A , and R B is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and two adjacent groups can be joined or fused to form a ring wherever chemically feasible, wherein the ligand L A is complexed to a metal M to form a chelate ring as indicated by the two dotted lines; the metal M can be coordinated to other ligands; the metal M is Ir; and the ligand L A can be linked with other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. 2. The compound of claim 1 , wherein each R, R′, R A and R B are independently selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein Z 1 is N, and Z 2 is C. 4. The compound of claim 1 , wherein Z 1 is C, and Z 2 is N. 5. The compound of claim 1 , wherein X 1 -X 3 are all C. 6. The compound of claim 1 , wherein ring A is pyridine, pyrimidine, pyrazine, imidazole, pyrazole, oxazole, thiazole, or imidazole derived carbene. 7. The compound of claim 1 , wherein X is NR′. 8. The compound of claim 7 , wherein R′ and R can be joined to form a ring wherever chemically feasible. 9. The compound of claim 1 , wherein Z 2 and X 1 -X 3 are all C. 10. The compound of claim 1 , wherein each of K 3 and K 4 is a direct bond. 11. The compound of claim 1 , wherein one of K 3 and K 4 is O. 12. The compound of claim 1 , wherein the ligand L A is selected from the group consisting of: wherein: R G for each occurrence represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; and each of R″ and R G is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and two adjacent R G groups can be joined together to form a ring wherever chemically feasible. 13. The compound of claim 1 , wherein the ligand L A is selected from the group consisting of the following structures: Ligand naming convention Structure L A 1-(j)(k)(p)(z), wherein each of j, k, p, and z is independently an integer from 1 to 55, wherein L A 1-(1)(1)(1)(1) to L A 1-(55)(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, Rp = Bp, and Rz = Bz, and L A 2-(j)(k)(p), wherein each of j, k, and p is independently an integer from 1 to 55, wherein L A 2-(1)(1)(1) to L A 2-(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, and Rp = Bp, and L A 3-(j)(z), wherein each of j, and z is independently an integer from 1 to 55, wherein L A 3-(1)(1) to L A 3-(55)(55) having the structure wherein Rj = Bj, and Rz = Bz, and L A 4-(j), wherein j is an integer from 1 to 55, wherein L A 4-(1) to L A 4-(55) having the structure wherein Rj = Bj, and L A 5-(j)(k), wherein each of j, and k is independently an integer from 1 to 55, wherein L A 5-(1)(1) to L A 5-(55)(55) having the structure wherein Rj = Bj, and Rk = Bk, and L A 6-(j)(k)(p)(z), wherein each of j, k, p, and z is independently an integer from 1 to 55, wherein L A 6-(1)(1)(1)(1) to L A 6-(55)(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, Rp = Bp, and Rz = Bz, and L A 7-(j)(k)(p), wherein each of j, k, and p is independently an integer from 1 to 55, wherein L A 7-(1)(1)(1) to L A 7-(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, and Rp = Bp, and L A 8-(j)(k)(z), wherein each of j, k, and z is independently an integer from 1 to 55, wherein L A 8-(1)(1)(1) to L A 8-(55)(55)(55) having the structure

Assignees

Inventors

Classifications

  • Organoboranes · CPC title

  • containing six or more rings · CPC title

  • containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene · CPC title

  • Organosilicon compounds, e.g. TIPS pentacene · CPC title

  • containing four rings, e.g. pyrene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12250875B2 cover?
Provided are compounds comprising a ligand L A of Formula I where the ligand L A is coordinated to Ir.
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0086. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).